Does AUMOLERTINIB Cause Neoplasm progression? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Neoplasm progression have been filed in association with AUMOLERTINIB. This represents 36.4% of all adverse event reports for AUMOLERTINIB.
8
Reports of Neoplasm progression with AUMOLERTINIB
36.4%
of all AUMOLERTINIB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Neoplasm progression From AUMOLERTINIB?
Of the 8 reports.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AUMOLERTINIB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does AUMOLERTINIB Cause?
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)